• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • Diagnostic Delay (in development)
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • Patient Fellows Program
    • Global CRLI
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Patient Fellows Program

The ALS/MND Patient Fellows Program is offered in person and virtually and is open to people living with ALS/MND, caregivers, and ALS/MND gene carriers.

The program focuses on bringing lived experience into global ALS/MND scientific conversations, with Patient Fellows participating in the MND Association’s International Symposium on ALS/MND. Fellows may also choose to register for the International Alliance’s Alliance Meeting and Allied Professionals Forum.

The Patient Fellows Program is open to people diagnosed with ALS/MND, caregivers and ALS/MND gene carriers. A volunteer committee selected applicants who will benefit most from the scientific discourse and who will share their experiences with the wider community.

Program Background

The Patient Fellows Program was created in 2015. Its mission is “Bringing People with ALS/MND and Caregivers into the Scientific Discourse.” It was first implemented in 2017 to help six people living with ALS/MND and their caregivers attend the MND Association’s International Research Symposium in Boston.  

‘Nothing about us without us.’ That’s the mantra of the Patient Fellows program, and honestly, it’s simply the right thing to do, especially in important scientific discussions.
– Cathy Collet, founder of the Patient Fellows Program

The outcomes for both the patient fellows and the research community were fantastic: the Patient Fellows asked meaningful questions throughout the event and continued to engage with the scientific community on an ongoing basis, which ensured that patient impact and support were considered in various initiatives. This has been the outcome every year since, and, in fact, many of our industry initiatives, like patient advocacy boards, are often populated with those whose first interaction with our community is through the program.

The Patient Fellows Program adds huge value to the Symposium. Most scientists have little contact with ALS/MND patients and caregivers, so the interaction between researchers and Patient Fellows adds an essential dimension to the meeting, generating new ideas and perspectives, and reminding the research community of the need for urgency and focus in the drive to turn knowledge into treatments.
– Dr. Brian Dickie, Director of Research Development, MND Association 

The Alliance has supported the Patient Fellows Program since its inception because we fundamentally believe that people with ALS/MND and their caregivers must be part of the discourse. As the program’s current leader, the Alliance hopes to expand the program’s reach, supporting local and international ALS/MND communities.

https://www.als-mnd.org/wp-content/uploads/2024/05/Alliance-Photobook.mp4

Program Details

As a Patient Fellow, you receive:

  • Registration for the MND Association’s International Symposium on ALS/MND (in-person or virtual) 
  • Access to valuable networking with researchers and fellow community members
  • Limited support for hotel and travel expenses for in-person attendees during the International Symposium 
  • Optional virtual registration for the International Alliance’s Alliance Meeting and Allied Professionals Forum (including ALS/MND Connect and the virtual Poster Hall)

Participation extends beyond the event itself. Patient Fellows become part of a supportive community committed to advancing ALS/MND research and advocacy.

For me, living in an ALS body that’s increasingly isolated, I start or tend to think of my experience as somehow mine alone. The greatest personal benefit of attending the Symposium was to remind me of the breadth of research and global nature of what I’m experiencing personally.
– Seth Christensen, 2020 Patient Fellow

Webinar: Highlights from the 2025 Patient Fellows

Highlights from the 2025 Patient Fellows brings together Patient Fellows from the 2025 cohort to share key learnings and reflections from their participation in the International Symposium on ALS/MND. This webinar explores how engaging directly in research discussions shaped participants’ perspectives, deepened their understanding of ALS/MND science, and reinforced the importance of including the voices of those living with ALS/MND in research conversations worldwide.

Support the Work of the Alliance 

If you would like to help expand the reach of the Patient Fellows Program and support greater participation by people living with ALS/MND and their caregivers, please consider making a donation. We deeply appreciate your support.

Past Patient Fellows

Whether attending virtually or in person, each patient fellow made valuable contributions to the scientific discourse surrounding ALS/MND. (* denotes in-person attendance)

2025 Fellows 2024 Fellows 2023 Fellows 2022 Fellows
Siti Nur Sabrina Binte Anis, Singapore
Mandi Bailey, USA*
David Buseck, USA*
Doug Butchart, USA*
Philip Camden, Australia
Xiaohui (Helen) Chen, UK*
Tammy de Witt, South Africa
Brooke Emmerich, USA*
Ronald Faretra, USA
Ingibjorg Gisladottir Lauvland, Norway*
Paige Higgins, Australia
Janet Hough, Australia
Gisli Jonasson, Iceland
Ashley Lee, USA
Stacy Lewin Farber, USA
Julio Neyra, Peru
Mehrdad Salehi, Iran*
Lea Storry, Canada*
Amanda Tam, Canada*
Giulia Valente, Australia*
Barry Werth, Australia
Michael Wilson, USA
 
 
Tre Archibald, Canada
Masher Ahmad, Pakistan
Mandi Bailey, USA*
Lynn Brielmaier, USA
Sunny Brous, USA*
David Buseck, USA*
Paige Higgins, Australia*
Janet Hough, Australia
Gisli Jonasson, Iceland*
Todd Kelly, USA
Ashlee Lee, USA
Stacy Lewin, MD, USA*
Debbie Lower, USA*
Sandra Mikush, USA
Sue Nelms, UK
Cali Orsulak, Canada*
Kaitlyn Pierce, USA*
Matthew Rocheleau, USA
Leanne Sklavenitis, Australia*
Paula Trefiak, Canada*
Barry Werth, Australia
Rick Zwiep, Canada
 
 
Alexis Behan, USA 
Lynn Brielmaier, USA 
David Buseck, USA*
Katrina Byrd, USA*
Robin Dewey, USA 
David Ray Freebury, Canada 
Lisa Galante, USA*
Cassandra Haddad, USA*
Gisli Jonasson, Iceland*
Ashley Lee, USA 
Dr. Stacy Lewin, USA 
Debbie Lower, USA 
Rick Nelms, UK*
Dr. Felipe Ocampo, USA 
Cali Orsulak, Canada 
Kevin Robinson, USA
David Shulman, USA*
Ananthprasad Babji Subba, AUS
Karen Sutton, USA 
Olive Brown, Canada
Douglas Butchart, USA
Jeffrey Derby, Canada
Patrick Dolan, USA
Brooke Eby, USA
Barri Falk, USA
Ray Freebury, Canada
Betty Fuchs, USA
Jack Gray, USA
Dr. Alper Kaya, Turkey
Stacy Lewin, USA
Ruth Longhurst, Canada
Roderick Malloy, USA
Cari Meystrik, USA
Rick Nelms, UK
Layne Oliff, USA
Cali Orsulak, Canada
Kevin Robinson, USA
Bruce Rosenbloom, USA
Karen Sutton, USA
Jennie Starkey, UK
Orlando Ruiz, Colombia
Karen Sutton, USA
Paula Trefiak, Canada
Martin Williams. UK

The value of the Program in terms of what it brings to PALS and CALS is probably immeasurable. It provides awareness, hope, encouragement and opportunities to help our community in many ways. Equally as important, it enables researchers and non-clinical medical people to meet and discuss matters and experiences with PALS and CALS, something that many lab-based folks rarely have the chance to do.
– Bruce Virgo, 2018 Patient Fellow

2021 Fellows 2020 Fellows 2019 Fellows 2018 Fellows 2017 Fellows
Malcolm Abernethy, NZ
Jennifer Barrett Fajardo, USA
Eben Cathey, USA
David Doane, USA
Jack Gray, USA
Cassandra Haddad, USA
Dr. Alper Kaya, Turkey
Steven Kowalski, USA
David LaForest, USA
Norman MacIssac, Canada
Jan Mattingly, Canada
Osiel Mendoza, USA
Cari Meystrik, USA
Layne Oliff, USA
Cali Orsulak, Canada
Juan Reyes, USA
Michael Robinson, USA
Orlando Ruiz, Colombia
Paula Trefiak, Canada
Seth Christensen, USA
Jack Gray, USA
Philip Green, USA
Madeline Kennedy, USA
Steven Kowalski, USA
Anna Maerker, UK
Jan Mattingly, Canada
Kenneth Menkhaus, USA
Cari Meystrek, USA
Michael Robinson, USA
Bert van Hoeijen, Canada
Erin Vierstra, USA
Ed Buckingham, USA*
Sunny Erasmus, USA*
Philip Green, USA*
Dave Healey, AUS*
Jonathan Jenson, USA*
Gwen Petersen, USA*
Sunny Erasmus, USA*
Keith Smith, UK*
Bruce Virgo, UK*
Stephen Finger, USA*
Andrea Lytle Peet, USA*
Meg Macdonald, USA*
Vic Walker, USA*
Sue Pondrom, USA*
Stephen Winthrop, USA*

 

 

 

 

 

Primary Sidebar

  • Rosie Riley, Les Turner ALS Foundation, USA

    Rosie Riley, Les Turner ALS Foundation, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

    Emilienne Verhaegen, ALS Liga Belgium, Diagnosed 2014

  • Shay Rishoni, Diagnosed 2011 - Prize4Life, Israel

    Shay Rishoni, Diagnosed 2011 – Prize4Life, Israel

  • Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

    Sam Hayden-Harler, Motor Neurone Disease (MND) Association, UK

  • Anthony (Tony) Lynch, MND New South Wales, Diagnosed 2016, Australia

    Anthony (Tony) Lynch, MND New South Wales, Diagnosed 2016, Australia

  • Ann Nicol

    Ann Nicol

  • Chih Ching Darren Wong, MND Malaysia

    Chih Ching Darren Wong, MND Malaysia

  • Ada Garrido Benavidez, Diagnosed 2016,  FYADENMAC, Mexico

    Ada Garrido Benavidez, Diagnosed 2016, FYADENMAC, Mexico

  • Danny Reviers, Diagnosed 1979 , ALS Liga België, Belgium

    Danny Reviers, Diagnosed 1979 , ALS Liga België, Belgium

  • Liam Dwyer, England

    Liam Dwyer, England

  • Cath Muir

    Cath Muir
    Cath

  • 83

    83

  • Jon Newsome, Les Turner ALS Foundation, USA

    Jon Newsome, Les Turner ALS Foundation, USA

  • Paul Launer, USA

    Paul Launer, USA

  • Jean

    Jean
    jean

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Greg Heydet, ALS Hope Foundation, USA

    Greg Heydet, ALS Hope Foundation, USA

  • Monica Soriano, Diagnosed 2011 ,  Asociación ELA , Argentina

    Monica Soriano, Diagnosed 2011 , Asociación ELA , Argentina

  • Wilfried Leusing, Diagnosed 2010 , DGM, Germany

    Wilfried Leusing, Diagnosed 2010 , DGM, Germany

  • Jason Goodman, Les Turner ALS Foundation, USA

    Jason Goodman, Les Turner ALS Foundation, USA

  • Claudette Sturk, ALS Society of Canada

    Claudette Sturk, ALS Society of Canada
    Picture2

  • Peng Yi-Wen

    Peng Yi-Wen

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Ailsa Malcolm-Hutton, Diagnosed 2013,  MND Association of England, Wales and N Ireland

    Ailsa Malcolm-Hutton, Diagnosed 2013, MND Association of England, Wales and N Ireland

  • John and Loretta Russo, USA

    John and Loretta Russo, USA
    final3878

  • Angela Jansen, Deutsche Gesellschaft für Muskelkranke e.V.-DGM, Diagnosed 1995, Germany

    Angela Jansen, Deutsche Gesellschaft für Muskelkranke e.V.-DGM, Diagnosed 1995, Germany

  • Bjarne Hytjanstorp, ALS Norge, Norway

    Bjarne Hytjanstorp, ALS Norge, Norway

  • Zabun Nassar, MND Association, Diagnosed 2016, England

    Zabun Nassar, MND Association, Diagnosed 2016, England

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

    Ana Lilia RodriguezApoyo Integral Gila A.C., Diagnosed 2018, Mexico

  • Dawn Morton, Diagnosed 2014 , MND Scotland, UK

    Dawn Morton, Diagnosed 2014 , MND Scotland, UK

  • Conny van der Meijden, Diagnosed 2001,  ALS Netherlands

    Conny van der Meijden, Diagnosed 2001, ALS Netherlands

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Maurice LeClerc, ALS Canada

    Maurice LeClerc, ALS Canada

  • Juvenal Bayona Romero

    Juvenal Bayona Romero

  • 727747090571358167

    727747090571358167

  • Jorge Melo, ABrELA, Brazil

    Jorge Melo, ABrELA, Brazil

  • David Bishop

    David Bishop

  • Ian Gale, MND Australia

    Ian Gale, MND Australia

  • Andrietta

    Andrietta

  • Michel Perrozzo, ARSLA, Diagnosed 2015, France

    Michel Perrozzo, ARSLA, Diagnosed 2015, France

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Steve

    Steve

  • Jean Waters, Diagnosed 2004, MND Association of England, Wales and N Ireland

    Jean Waters, Diagnosed 2004, MND Association of England, Wales and N Ireland

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Joy Blakeley, Diagnosed 2017 , MND Australia

    Joy Blakeley, Diagnosed 2017 , MND Australia

  • Sanjay Kumar Srivastava, Asha Ek Hope Foundation for ALS/MND, Diagnosed 2018, India

    Sanjay Kumar Srivastava, Asha Ek Hope Foundation for ALS/MND, Diagnosed 2018, India

  • Susan Anderson, Diagnosed 2014 , Hope Loves Company,  USA

    Susan Anderson, Diagnosed 2014 , Hope Loves Company, USA

  • Timmy, ALS Liga

    Timmy, ALS Liga

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login